BioSpecifics receives $426,000 grant under QTDP Program BioSpecifics Technology Corp. , a biopharmaceutical firm developing first in course collagenase-based items, today announced that it offers received $426,000 in grant funding beneath the Qualifying Therapeutic Discovery Task Program. The scheduled program, funded through the united states Patient Affordable and Safety Care Act of 2010, supports therapeutic discovery applications. We have become excited that the federal government has acknowledged the potential of our advancement applications and awarded these grants to us, commented Thomas L. Wegman, President of BioSpecifics. We are looking towards initiating a new scientific trial in lipomas and focusing on improved collagenase in neuro-scientific tissue disassociation.Light destroys vitamin B2. When storing flour products, dairy or meat, to avoid loss of riboflavin using opaque areas or containers protected from light. Due to this sensitivity to light, riboflavin in milk kept in a bottle or exposed to ultraviolet rays from the sun disappear at a rate of 85 percent in about 2 hours. Alkaline environment and food irradiation cause lack of vitamin B2 in food. Attention! Prolonged administration of a single B vitamin can cause imbalances of various other B vitamin supplements. Normally, a daily balanced diet contains vitamin B2, with no need for nutritional products. Consult your physician to determine the need and how to administrate any supplements.